Beijing Chunlizhengda Medical Instruments (01858) releases 2024 annual performance report, with a net profit attributable to the parent company of 125 million yuan, a decrease of 55.01% year-on-year.

Beijing Chunlizhengda Medical Instruments (01858) released its 2024 annual performance report, with total revenue of 806 million yuan, a year-on-year decrease of 33.32%; net profit attributable to shareholders of 1.25 billion yuan, a year-on-year decrease of 55.01%; basic earnings per share of 0.33 yuan. The announcement stated that during the reporting period, the centralized procurement policy continued to deepen, and the company actively implemented the national centralized volume procurement policy, resulting in a decrease in product prices and profit, affecting the company's performance.